Company profilePharmaceutical#590 of 1,318 in Pakistan✓ No DRAP alerts

SCHARPER PHARMACEUTICALS (PVT) LTD.

Pharmaceutical company · 20 brands · 19 molecules

Ranked #119 of 178 companies in Antiinflammatory And Antirheumatic Products

20 registered products 14 pharmaceutical brands 19 distinct molecules 0 DRAP alerts

Company overview

20
registered products
14
pharmaceutical brands
19
distinct molecules
4
therapeutic classes
0
DRAP alerts

SCHARPER PHARMACEUTICALS (PVT) LTD. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 20 product registrations across 19 distinct molecules. Its portfolio is concentrated in Antiinflammatory And Antirheumatic Products and Other Anti-Baterials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by SCHARPER

1 product matched in our catalogue — each with its observed price and DRAP approved ceiling.

Other Anti-Baterials 1

Top molecules by brand count

Heparin And Heparin1 brand
Cefuroxime1 brand
Nimesulide1 brand
Megestrol1 brand
Fosfomycin1 brand

Therapeutic classes

Antiinflammatory And Antirheumatic Products · 2Other Anti-Baterials · 1Antispasmodic & Anticholinergic · 1Cough Expectorant · 1

Price band (DRAP official ceilings)

Registered products priced by source
DVAGO1 products · Rs 1,067.45 – Rs 1,067.45
Median across source: Rs 1,067.45

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

SHROOQ PHARMACEUTICALS holds 22 molecules not in this portfolio
AcitretinAcyclovirAcyclovir Inf/OralCefiximeCiprofloxacinDiclofenac
Pharmedic Pharmaceuticals Industries (Pvt.) Ltd. holds 93 molecules not in this portfolio
Actinomycin DAlbendazoleAmitriptylineAmlodipineAmoxicillin BaseArtemether
ENGLISH PHARMACEUTICALS INDUSTRIES holds 71 molecules not in this portfolio
000 I.UAmikacinAmoxicillinAmoxicillin BaseAmoxycillin BaseAmpicillin

Get the full profile for SCHARPER

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.